Collegium Pharmaceutical, Inc. COLL Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from Collegium Pharmaceutical, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s interest coverage?
- Collegium Pharmaceutical, Inc. (COLL) reported interest coverage of 2.4× in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s interest coverage changed year-over-year?
- Collegium Pharmaceutical, Inc.'s interest coverage increased by 33.0% year-over-year, from 1.8× to 2.4×.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s interest coverage?
- Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s interest coverage has grown at a 2.3% compound annual growth rate (CAGR), from 1.9× to 2.2×.
- What does interest coverage mean?
- Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.